Noninvasive prenatal diagnosis of monogenic disorders

Bibliography

• Mujezinovic F, Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol 2007;110:687-94
   PubMed Web of Science ®Google Scholar
• Kozlowski P, Knippel A, Stressig R. Individual risk of fetal loss following routine second trimester amniocentesis: a controlled study of 20,460 cases. Ultraschall Med 2008;29:165-72
   PubMed Web of Science ®Google Scholar
• Herzenberg LA, Bianchi DW, Schroeder J, Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence-activated cell sorting. Proc Natl Acad Sci USA 1979;76:1453-5
   PubMed Web of Science ®Google Scholar
• Rodriguez de Alba M, Palomino P, Jurado A, Prenatal diagnosis on fetal cells obtained from maternal peripheral blood: report of 66 cases. Prenat Diagn 1999;19:934-40
   PubMed Web of Science ®Google Scholar
• Rodriguez de Alba M, Palomino P, Gonzalez-Gonzalez C, Prenatal diagnosis on fetal cells from maternal blood: practical comparative evaluation of the first and second trimesters. Prenat Diagn 2001;21:165-70
   PubMed Web of Science ®Google Scholar
• Sekizawa A, Kimura T, Sasaki M, Prenatal diagnosis of Duchenne muscular dystrophy using a single fetal nucleated erythrocyte in maternal blood. Neurology 1996;46:1350-3
   PubMed Web of Science ®Google Scholar
• Kimura T, Sekizawa A, Taguti A, Prenatal diagnosis of Duchenne muscular dystrophy using single fetal cell in maternal blood. Nihon Rinsho 1997;55:3137-41
   PubMedGoogle Scholar
• Watanabe A, Sekizawa A, Taguchi A, Prenatal diagnosis of ornithine transcarbamylase deficiency by using a single nucleated erythrocyte from maternal blood. Hum Genet 1998;102:611-15
   PubMed Web of Science ®Google Scholar
• Lo YM, Corbetta N, Chamberlain PF, Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-7
   PubMed Web of Science ®Google Scholar
• Leon SA, Shapiro B, Sklaroff DM, Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1997;37:646-50
   Google Scholar
• Bustamante-Aragones A, Rodriguez de Alba M, Gonzalez-Gonzalez C, Foetal sex determination in maternal blood from the seventh week of gestation and its role in diagnosing haemophilia in the foetuses of female carriers. Haemophilia 2008;14:593-8
   PubMed Web of Science ®Google Scholar
• Lo YM, Tein MS, Lau TK, Quantitative analysis of fetal DNA in maternal plasma and serum: implications for non-invasive prenatal diagnosis. Am J Hum Genet 1998;62:768-75
   PubMed Web of Science ®Google Scholar
• Zhong XY, Burk MR, Troeger C, Fluctuation of maternal and fetal free extracellular circulatory DNA in maternal plasma. Obstet Gynecol 2000;96:991-6
   PubMed Web of Science ®Google Scholar
• Hahn S, Zhong XY, Burk MR, Both maternal and fetal free DNA in plasma fluctuate. Ann NY Acad Sci 2001;945:141-4
   PubMed Web of Science ®Google Scholar
• Lun FM, Chiu RW, Allen Chan KC, Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem 2008;54:1664-72
   PubMed Web of Science ®Google Scholar
• Chan KC, Zhang J, Hui AB, Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 2004;50:88-92
   PubMed Web of Science ®Google Scholar
• Chiu RW, Akolekar R, Zheng YW, Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011;342:c7401
   PubMed Web of Science ®Google Scholar
• Ehrich M, Deciu C, Zwiefelhofer T, Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011;204:205.e1-11
   PubMed Web of Science ®Google Scholar
• Tong YK, Chiu RW, Akolekar R, Epigenetic-genetic chromosome dosage approach for fetal trisomy 21 detection using an autosomal genetic reference marker. PLoS One 2010;5:e15244
   PubMed Web of Science ®Google Scholar
• Chen EZ, Chiu RW, Sun H, Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One 2011;6:e21791
   PubMed Web of Science ®Google Scholar
• Lo YM, Chiu RW. Next-generation sequencing of plasma/serum DNA: an emerging research and molecular diagnostic tool. Clin Chem 2009;55:607-8
   PubMed Web of Science ®Google Scholar
• Dennis Lo Y, Chiu RW. Plasma nucleic acid analysis by massively parallel sequencing: pathological insights and diagnostic implications. J Pathol 2011;225:318-23
   PubMed Web of Science ®Google Scholar
• Palomaki GE, Kloza EM, Lambert-Messerlian GM, DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011;13:913-20
   PubMed Web of Science ®Google Scholar
• Sekizawa A, Watanabe A, Kimura T, Prenatal diagnosis of the fetal RhD blood type using a single fetal nucleated erythrocyte from maternal blood. Obstet Gynecol 1996;87:501-5
   PubMed Web of Science ®Google Scholar
• Saito H, Sekizawa A, Morimoto T, Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet 2000;356:1170
   PubMed Web of Science ®Google Scholar
• Maron JL, Bianchi DW. Prenatal diagnosis using cell-free nucleic acids in maternal body fluids: a decade of progress. Am J Med Genet C Semin Med Genet 2007;145C:5-17
   PubMed Web of Science ®Google Scholar
• Clausen FB, Krog GR, Rieneck K, Improvement in fetal DNA extraction from maternal plasma. Evaluation of the NucliSens magnetic extraction system and the QIAamp DSP Virus Kit in comparison with the QIAamp DNA Blood Mini Kit. Prenat Diagn 2007;27:6-10
   PubMed Web of Science ®Google Scholar
• Legler TJ, Heermann KH, Liu Z, Fetal DNA: strategies for optimal recovery. Methods Mol Biol 2008;444:209-18
   PubMedGoogle Scholar
• Bustamante-Aragones A, Perez-Cerda C, Perez B, Prenatal diagnosis in maternal plasma of a fetal mutation causing propionic acidemia. Mol Genet Metab 2008;95:101-3
   PubMed Web of Science ®Google Scholar
• Bustamante-Aragones A, Gallego-Merlo J, Trujillo-Tiebas MJ, New strategy for the prenatal detection/exclusion of paternal cystic fibrosis mutations in maternal plasma. J Cyst Fibros 2008;7:505-10
   PubMed Web of Science ®Google Scholar
• Ding C, Chiu RW, Lau TK, MS analysis of single-nucleotide differences in circulating nucleic acids: application to noninvasive prenatal diagnosis. Proc Natl Acad Sci USA 2004;101:10762-7
   PubMed Web of Science ®Google Scholar
• Lo YM, Tsui NB, Chiu RW, Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 2007;13:218-23
   PubMed Web of Science ®Google Scholar
• Dhallan R, Au WC, Mattagajasingh S, Methods to increase the percentage of free fetal DNA recovered from the maternal circulation. JAMA 2004;291:1114-19
   PubMed Web of Science ®Google Scholar
• Tong YK, Jin S, Chiu RW, Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. Clin Chem 2010;56:90-8
   PubMed Web of Science ®Google Scholar
• Lo YM, Lun FM, Chan KC. Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci USA 2007;104:13116-21
   PubMed Web of Science ®Google Scholar
• Tsui NB, Kadir RA, Chan KC, Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA. Blood 2011;117:3684-91
   PubMed Web of Science ®Google Scholar
• Lo DYM, Chan KCA, Sun H, Maternal plasma DNA sequencing reveals the genome-wide genetics and mutational profile of the fetus. Sci Transl Med 2010;2:61ra91
   PubMed Web of Science ®Google Scholar
• Finning KM, Martin PG, Soothill PW, Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 2002;42:1079-85
   PubMed Web of Science ®Google Scholar
• Finning KM, Chitty LS. Non-invasive fetal sex determination: impact on clinical practice. Semin Fetal Neonatal Med 2008;13:69-75
   PubMed Web of Science ®Google Scholar
• Scheffer PG, van der Schoot CE, Page-Christiaens GC, Reliability of fetal sex determination using maternal plasma. Obstet Gynecol 2010;115:117e26
   Google Scholar
• Devaney SA, Palomaki GE, Scott JA, Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis. JAMA 2011;306:627-36
   PubMed Web of Science ®Google Scholar
• Bustamante-Aragones A, Garcia-Hoyos M, Rodriguez De Alba M, Detection of a paternally inherited fetal mutation in maternal plasma by the use of automated sequencing. Ann NY Acad Sci 2006;1075:108-17
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gonzalez MC, Trujillo MJ, Rodriguez de Alba M, Early Huntington disease prenatal diagnosis by maternal semi quantitative fluorescent-PCR. Neurology 2003;60:1214-15
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gonzalez MC, Trujillo MJ, Rodriguez de Alba M, Huntington disease-unaffected fetus diagnosed from maternal plasma using QF-PCR. Prenat Diagn 2003;23:232-4
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gonzalez MC, Garcia-Hoyos M, Trujillo-Tiebas MJ, Improvement in strategies for the non-invasive prenatal diagnosis of Huntington disease. J Assist Reprod Genet 2008;25:477-81
   PubMed Web of Science ®Google Scholar
• Bustamante-Aragones A, Trujillo-Tiebas MJ, Gallego-Merlo J, Prenatal diagnosis of Huntington disease in maternal plasma: direct and indirect study. Eur J Neurol 2008;15:1338-44
   PubMed Web of Science ®Google Scholar
• Amicucci P, Gennarelli M, Novelli G, Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem 2000;46:301-2
   PubMed Web of Science ®Google Scholar
• Meaney C, Norbury G. Noninvasive prenatal diagnosis of early onset primary dystonia I in maternal plasma. Prenat Diagn 2009;29:1218-21
   PubMed Web of Science ®Google Scholar
• Chiu RW, Lau TK, Cheung PT, Non invasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study. Clin Chem 2002;48:778-80
   PubMed Web of Science ®Google Scholar
• Tungwiwat W, Fucharoen S, Fucharoen G, Development and application of a real-time quantitative PCR for prenatal detection of fetal alpha(0)-thalassemia from maternal plasma. Ann NY Acad Sci 2006;1075:103-7
   PubMed Web of Science ®Google Scholar
• Chiu RW, Lau TK, Leung TN, Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet 2002;360:998-1000
   PubMed Web of Science ®Google Scholar
• Fucharoen G, Tungwiwat W, Ratanasiri T, Prenatal detection of fetal hemoglobin E gene from maternal plasma. Prenat Diagn 2003;23:393-6
   PubMed Web of Science ®Google Scholar
• Papasavva T, Kalakoutis G, Kalikas I, Noninvasive prenatal diagnostic assay for the detection of beta-thalassemia. Ann NY Acad Sci 2006;1075:148-53
   PubMed Web of Science ®Google Scholar
• Papasavva T, Kalikas I, Kyrri A, Arrayed primer extension for the noninvasive prenatal diagnosis of beta-thalassemia based on detection of single nucleotide polymorphisms. Ann NY Acad Sci 2008;1137:302-8
   PubMed Web of Science ®Google Scholar
• Tungwiwat W, Fucharoen G, Fucharoen S, Application of maternal plasma DNA analysis for noninvasive prenatal diagnosis of Hb E-beta-thalassemia. Transl Res 2007;150:319-25
   PubMed Web of Science ®Google Scholar
• Lun FM, Tsui NB, Chan KC, Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma. Proc Natl Acad Sci 2008;105:19920-5
   PubMed Web of Science ®Google Scholar
• Li Y, Di Naro E, Vitucci A, Size fractionation of cell-free DNA in maternal plasma improves the detection of a paternally inherited beta-thalassemia point mutation by MALDI-TOF mass spectrometry. Fetal Diagn Ther 2009;25:246-9
   PubMed Web of Science ®Google Scholar
• Chan K, Yam I, Leung KY, Detection of paternal alleles in maternal plasma for non-invasive prenatal diagnosis of beta-thalassemia: a feasibility study in southern Chinese. Eur J Obstet Gynecol Reprod Biol 2010;150:28-33
   PubMed Web of Science ®Google Scholar
• Lo YM, Chiu RW. Noninvasive approaches to prenatal diagnosis of hemoglobinopathies using fetal DNA in maternal plasma. Hematol Oncol Clin North Am 2010;24:1179-86
   PubMed Web of Science ®Google Scholar
• Yi P, Chen Z, Yu L, Development of a pcr/ldr/capillary electrophoresis assay with potential for the detection of a beta-thalassemia fetal mutation in maternal plasma. J Matern Fetal Neonatal Med 2010;23:920-7
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gonzalez MC, Garcia-Hoyos M, Trujillo MJ, Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenat Diagn 2002;22:946-8
   PubMed Web of Science ®Google Scholar
• Nasis O, Thompson S, Hong T, Improvement in sensitivity of allele-specific PCR facilitates reliable noninvasive prenatal detection of cystic fibrosis. Clin Chem 2004;50:694-701
   PubMed Web of Science ®Google Scholar
• Bustamante-Aragones A, Gallego-Merlo J, Trujillo-Tiebas MJ, New strategy for the prenatal detection/exclusion of paternal cystic fibrosis mutations in maternal plasma. J Cyst Fibros 2008;7:505-10
   PubMed Web of Science ®Google Scholar
• Bustamante-Aragones A, Vallespin E, Rodriguez de Alba M, Early noninvasive prenatal detection of a fetal CRB1 mutation causing Leber congenital amaurosis. Mol Vis 2008;4:1388-94
   Google Scholar
• Bustamante-Aragones A, Perez-Cerda C, Perez B, Prenatal diagnosis in maternal plasma of a fetal mutation causing propionic acidemia. Mol Genet Metab 2008;95:101-3
   PubMed Web of Science ®Google Scholar
• Rijnders RJ, van der Schoot CE, Bossers B, Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia. Obstet Gynecol 2001;98:374-8
   PubMed Web of Science ®Google Scholar
• Bartha JL, Finning K, Soothill PW. Fetal sex determination from maternal blood at 6 weeks of gestation when at risk for 21-hydroxylase deficiency. Obstet Gynecol 2003;101:1135-6
   PubMed Web of Science ®Google Scholar
• Li Y, Holzgreve W, Page-Christiaens GC, Improved prenatal detection of a fetal point mutation for achondroplasia by the use of size-fractionated circulatory DNA in maternal plasma–case report. Prenat Diagn 2004;24:896-8
   PubMed Web of Science ®Google Scholar
• Li Y, Page-Christiaens GC, Gille JJ, Non-invasive prenatal detection of achondroplasia in size-fractionated cell-free DNA by MALDI-TOF MS assay. Prenat Diagn 2007;27:11-17
   PubMed Web of Science ®Google Scholar
• Lim JH, Kim MJ, Kim SY, Non-invasive prenatal detection of achondroplasia using circulating fetal DNA in maternal plasma. J Assist Reprod Genet 2010;28:167-72
   PubMed Web of Science ®Google Scholar
• Chitty LS, Griffin DR, Meaney C, New aids for the non-invasive prenatal diagnosis of achondroplasia: dysmorphic features, charts of fetal size and molecular confirmation using cell-free fetal DNA in maternal plasma. Ultrasound Obstet Gynecol 2011;37:283-9
   PubMed Web of Science ®Google Scholar
• Harton G, Braude P, Lashwood A, ESHRE PGD consortium best practice guidelines for organization of a PGD centre for PGD/preimplantation genetic screening. Hum Reprod 2011;26:14-24
   PubMed Web of Science ®Google Scholar